Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells

International Journal of Oncology

Volumn 45, Issue 4, 2014, Pages 1715-1723

  Götze, Silke ^a   Coersmeyer, Monique ^b   Müller, Oliver ^c   Sievers, Sonja ^a  

^a MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

^b SWISS INST FOR EXP CANCER RESEARCH   (Switzerland)

^c UNIVERSITY OF APPLIED SCIENCES   (Germany)

Author keywords

Colon carcinoma; Histone deacetylase inhibitors; TCF7L2; Wnt signaling

Indexed keywords

HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROXAMIC ACID; PROTEASOME; TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN; ANTINEOPLASTIC AGENT; HDAC10 PROTEIN, HUMAN; HDAC6 PROTEIN, HUMAN; TCF7L2 PROTEIN, HUMAN;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL PROLIFERATION; CELL VIABILITY; COLORECTAL CARCINOMA; CONTROLLED STUDY; DRUG MECHANISM; HISTONE ACETYLATION; METASTASIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ACETYLATION; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HCT116 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ACETYLATION; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HISTONE DEACETYLASE INHIBITORS; HISTONE DEACETYLASES; HUMANS; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; WNT SIGNALING PATHWAY;

EID: 84907466558     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2550     Document Type: Article

References (38)

1. Insinga A, Monestiroli S, Ronzoni S, et al: Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 11: 71-76, 2005. (Pubitemid 40215840)
2. Schrump DS: Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications. Clin Cancer Res 15: 3947-3957, 2009.
3. Rada-Iglesias A, Enroth S, Ameur A, et al: Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes. Genome Res 17: 708-719, 2007. (Pubitemid 46919708)
4. Hu J and Colburn NH: Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding. Mol Cancer Res 3: 100-109, 2005. (Pubitemid 40271140)
5. Luo J, Li M, Tang Y, Laszkowska M, Roeder RG and Gu W: Acetylation of p53 augments its site-specific DNA binding both in vitro and in vivo. Proc Natl Acad Sci USA 101: 2259-2264, 2004. (Pubitemid 38269299)
6. Jin YH, Jeon EJ, Li QL, et al: Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J Biol Chem 279: 29409-29417, 2004.
7. Piekarz RL and Bates SE: Epigenetic modifiers: basic understanding and clinical development. Clin Cancer Res 15: 3918-3926, 2009.
8. Kim HJ and Bae SC: Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res 3: 166-179, 2011.
9. Kobayashi H, Tan EM and Fleming SE: Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells. Int J Cancer 109: 207-213, 2004. (Pubitemid 38240922)
10. Chen YX, Fang JY, Zhu HY, Lu R, Cheng ZH and Qiu DK: Histone acetylation regulates p21WAF1 expression in human colon cancer cell lines. World J Gastroenterol 10: 2643-2646, 2004. (Pubitemid 39214494)
11. Zhu P, Martin E, Mengwasser J, Schlag P, Janssen KP and Gottlicher M: Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer Cell 5: 455-463, 2004. (Pubitemid 38610247)
12. Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature 434: 843-850, 2005. (Pubitemid 40558990)
13. Willert K and Jones KA: Wnt signaling: is the party in the nucleus? Genes Dev 20: 1394-1404, 2006. (Pubitemid 43830647)
14. Morin PJ, Sparks AB, Korinek V, et al: Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275: 1787-1790, 1997. (Pubitemid 27136715)
15. Lallemand F, Courilleau D, Sabbah M, Redeuilh G and Mester J: Direct inhibition of the expression of cyclin D1 gene by sodium butyrate. Biochem Biophys Res Commun 229: 163-169, 1996. (Pubitemid 27013725)
16. Kim MS, Kwon HJ, Lee YM, et al: Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. Nat Med 7: 437-443, 2001. (Pubitemid 32298546)
17. Bordonaro M, Lazarova DL, Augenlicht LH and Sartorelli AC: Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate. Int J Cancer 97: 42-51, 2002.
18. Heruth DP, Zirnstein GW, Bradley JF and Rothberg PG: Sodium butyrate causes an increase in the block to transcriptional elongation in the c-myc gene in SW837 rectal carcinoma cells. J Biol Chem 268: 20466-20472, 1993. (Pubitemid 23278957)
19. Varshavsky A, Bachmair A and Finley D: The N-end rule of selective protein turnover: mechanistic aspects and functional implications. Biochem Soc Trans 15: 815-816, 1987.
20. Huang X and Guo B: Adenomatous polyposis coli determines sensitivity to histone deacetylase inhibitor-induced apoptosis in colon cancer cells. Cancer Res 66: 9245-9251, 2006. (Pubitemid 44521146)
21. Mologni L, Cleris L, Magistroni V, et al: Valproic acid enhances bosutinib cytotoxicity in colon cancer cells. Int J Cancer 124: 1990-1996, 2009.
22. Jin JS, Tsao TJ, Sun PC, Yu CT and Tzao C: SAHA inhibits the growth of colon tumors by decreasing histone deacetylase and the expression of cyclin D1 and survivin. Pathol Oncol Res 18: 713-720, 2012.
23. Hsu YF, Sheu JR, Lin CH, et al: Trichostatin A and sirtinol suppressed survivin expression through AMPK and p38MAPK in HT29 colon cancer cells. Biochim Biophys Acta 1820: 104-115, 2012.
24. Young DA, Lakey RL, Pennington CJ, et al: Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption. Arthritis Res Ther 7: R503-R512, 2005.
25. Wolf D, Rodova M, Miska EA, Calvet JP and Kouzarides T: Acetylation of beta-catenin by CREB-binding protein (CBP). J Biol Chem 277: 25562-25567, 2002. (Pubitemid 34951872)
26. Levy L, Wei Y, Labalette C, et al: Acetylation of beta-catenin by p300 regulates beta-catenin-Tcf4 interaction. Mol Cell Biol 24: 3404-3414, 2004. (Pubitemid 38452083)
27. Nimmanapalli R, Fuino L, Bali P, et al: Histone deacetylase inhibitor LAQ824 both lowers expression and promotes proteasomal degradation of Bcr-Abl and induces apoptosis of imatinib mesylate-sensitive or -refractory chronic myelogenous leukemia-blast crisis cells. Cancer Res 63: 5126-5135, 2003. (Pubitemid 37022654)
28. Korinek V, Barker N, Morin PJ, et al: Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275: 1784-1787, 1997. (Pubitemid 27136714)
29. Bolden JE, Peart MJ, Johnstone RW: Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 5: 769-784, 2006. (Pubitemid 44348499)
30. Bali P, Pranpat M, Bradner J, Balasis M, et al: Inhibition of histone deacetylase 6 acetylates and disrupts the chaperone function of heat shock protein 90: a novel basis for antileukemia activity of histone deacetylase inhibitors. J Biol Chem 280: 26729-26734, 2005. (Pubitemid 41040705)
31. Park JH, Kim SH, Choi MC, et al: Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors. Biochem Biophys Res Commun 368: 318-322, 2008.
32. New M, Olzscha H and La Thongue NB: HDAC inhibitor-based therapies: Can we interpret the code? Mol Oncol 6: 637-656, 2012.
33. Kurashina R, Ohyashiki JH, Kobayashi C, et al: Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells. Cancer Lett 284: 62-70, 2009.
34. Jiang Y, Zhou XD, Liu YK, et al: Antisense Tcf inhibits the neoplastic growth of liver cancer cells. J Cancer Res Clin Oncol 130: 671-678, 2004. (Pubitemid 39506381)
35. Morin PJ, Vogelstein B and Kinzler KW: Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci USA 93: 7950-7954, 1996. (Pubitemid 26277145)
36. He B, You L, Uematsu K, et al: A monoclonal antibody against Wnt-1 induces apoptosis in human cancer cells. Neoplasia 6: 7-14, 2004. (Pubitemid 38391944)
37. Minke KS, Staib P, Puetter A, et al: Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells. Eur J Haematol 82: 165-175, 2009.
38. Chen S, Guttridge DC, You Z, et al: Wnt-1 signaling inhibits apoptosis by activating beta-catenin/T cell factor-mediated transcription. J Cell Biol 152: 87-96, 2001. (Pubitemid 32102439)